Emergency Use of Tocilizumab in Moderate and Severe COVID-19 Patients over the Prevaccination Stage during the Pandemic in Mexico

INTRODUCTION: COVID-19 has been associated with the overactivation of the immune system; interleukin-6 (IL-6) seems to have a key role, which made its moderation to be proposed as a therapeutic blank. Tocilizumab has been used as part of treatments to modulate the immune response to infections cause...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernal Luna, Yessica, Esquivel Loza, Alejandro, Garduño García, José de Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747308/
https://www.ncbi.nlm.nih.gov/pubmed/36524015
http://dx.doi.org/10.1155/2022/6880405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747308/
https://www.ncbi.nlm.nih.gov/pubmed/36524015
http://dx.doi.org/10.1155/2022/6880405

Ejemplares similares